Biliary Tract Carcinoma
📧 Sign up to get email alerts when something new happens for Biliary Tract Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-16Clinical Trial Update: A Study of Different Dosing Schedules of Selumetinib With Cisplatin/Gemcitabine (CIS/GEM) Versus CIS/GEM Alone in Biliary Cancer [Phase 2]
A Phase 2 trial evaluating different dosing schedules of selumetinib in combination with cisplatin and gemcitabine versus cisplatin/gemcitab…
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: SBRT Sequential Surufatinib Combined With Immunotherapy for Biliary Tract Carcinoma [Phase 2]
A Phase 2 trial examining SBRT followed by surufatinib with immunotherapy for biliary tract carcinoma is currently suspended.
-
CLINICAL_TRIALS trial_result · 2024-05-17Clinical Trial Update: Liposomal Irinotecan, Fluorouracil, Leucovorin Calcium, and Rucaparib in Treating Patients With Metastatic Pancreatic, Colorectal, Gastroesophageal, or Biliary Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial update reports results for a combination of liposomal irinotecan, fluorouracil, leucovorin, and rucaparib in pati…
-
CLINICAL_TRIALS trial_result · 2023-12-26Clinical Trial Update: Pembrolizumab (MK-3475) Plus Gemcitabine/Cisplatin Versus Placebo Plus Gemcitabine/Cisplatin for First-Line Advanced and/or Unresectable Biliary Tract Carcinoma (BTC) (MK-3475-966/KEYNOTE-966)-China Extension Study [Phase 3]
Phase 3 China extension study comparing pembrolizumab plus gemcitabine/cisplatin against placebo plus gemcitabine/cisplatin as first-line tr…
-
CLINICAL_TRIALS trial_result · 2023-10-13Clinical Trial Update: Olaparib in Treating Patients With Metastatic Biliary Tract Cancer With Aberrant DNA Repair Gene Mutations [Phase 2]
Phase 2 trial investigating olaparib for metastatic biliary tract cancer with aberrant DNA repair gene mutations.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-08-15Clinical Trial Update: GP Chemotherapy in Combination With Anti-PD-1 and Anti-TIGIT in Unresectable Advanced BTC [Phase 2]
A Phase 2 trial evaluating GP chemotherapy in combination with anti-PD-1 and anti-TIGIT in unresectable advanced biliary tract carcinoma is …
-
CLINICAL_TRIALS trial_result · 2021-08-09Clinical Trial Update: GEMOX Combined With Donafenib and Tislelizumab in Biliary Tract Cancer [Phase 1, Phase 2]
Clinical trial of GEMOX with donafenib and tislelizumab in biliary tract carcinoma is in Phase 1/2 with unknown results to date.
-
CLINICAL_TRIALS trial_result · 2020-11-17Clinical Trial Update: First Line Gemcitabine, Cisplatin and MEK162 in Advanced Biliary Tract Carcinoma [Phase 1, Phase 2]
A Phase 1/2 trial evaluating first-line gemcitabine, cisplatin, and MEK162 in advanced biliary tract carcinoma has completed with results po…